ClarityDX Prostate is a rapid test providing critical support to men and their physicians to make more informed decisions, with 3X the accuracy, about whether to biopsy after a high PSA test result. Order your test at nanosticsdx.com/clarity-dx-p…#prostatecancer#ClarityDXProstate
Coming up later this #LifeSciencesWeek: @nanostics will officially launch ClarityDX Prostate in Alberta- a new test that substantially improves the prediction of clinically significant prostate cancer.
Head now to lifesciencesweek.ca to join this celebratory event!
We welcome Todd McMullen as Nanostics’ Medical Laboratory Director. His expertise is invaluable as we launch ClarityDX Prostate, our prostate cancer test to improve patient care by accurately identifying men with high-risk cancer. bit.ly/3N5UIR0
Looking forward to #ASCO23! Dr. Chris Wallis will present "Clinical analysis of a ML risk model to predict clinically significant prostate cancer and avoid unnecessary prostate biopsies". Please chat with Dr. Wallis! #diagnostics#prostatecancer#precisionhealth@WallisCJD
April 26, 2:10 pm MT, our CSO Desmond Pink is presenting "EVs and ML: novel diagnostic tools for bladder cancer detection" @ABInnovates 1st Health Gamechangers: Impact of Digital Tech in Research. See you there! @PinkDes#bladdercancer#diagnostics#uofa
The FIRST @ABInnovates Health Gamechangers Research Conference is SOLD OUT with over 180 registered!
Looking forward to seeing everyone there!
#Digitalhealth#Research
COO Catalina Vasquez is at the Canadian Women's Network pathway for Silicon Valley this week networking, learning, and building industry connections with investors, execs & founders in Silicon Valley. More info nanosticsdx.com/events/#prostatecancer#diagnostics#networking